Cargando…
Delayed seropositivity is associated with lower levels of SARS-CoV-2 antibody levels in patients with mild to moderate COVID-19
BACKGROUND: Patients with COVID-19 can develop a range of immune responses, including variations in the onset and magnitude of antibody formation. The aim of this study was to investigate whether SARS-CoV-2 antibody levels vary in patients with mild to moderate COVID-19 in relation to the onset (day...
Autores principales: | Fekry, Marwa M., Soliman, Hanan, Hashish, Mona H., Selim, Heba S., Osman, Nermin A., Omran, Eman A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027427/ https://www.ncbi.nlm.nih.gov/pubmed/36941519 http://dx.doi.org/10.1186/s42506-023-00131-x |
Ejemplares similares
-
Asymptomatic versus symptomatic SARS-CoV-2 infection: a cross-sectional seroprevalence study
por: El-Ghitany, Engy Mohamed, et al.
Publicado: (2022) -
Predictors of anti-SARS-CoV-2 seropositivity: An Egyptian population-based study
por: El-Ghitany, Engy Mohamed, et al.
Publicado: (2022) -
“Day 25”: a temporal indicator of stabilization of mortality risk among COVID-19 patients with high viral load
por: Osman, Nancy A., et al.
Publicado: (2022) -
Anti-Spike and Neutralizing Antibodies after Two Doses of COVID-19 Sinopharm/BIBP Vaccine
por: Omran, Eman A., et al.
Publicado: (2022) -
Microbiological quality of some packed and unpacked bread products in Alexandria, Egypt
por: Ali, Manal A., et al.
Publicado: (2023)